Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

October 01, 1995; Volume 48,Issue 4
  • You have access
    Localization of P2X purinoceptor transcripts in the rat nervous system.
    E J Kidd, C B Grahames, J Simon, A D Michel, E A Barnard and P P Humphrey
    Molecular Pharmacology October 1995, 48 (4) 569-573;
  • You have access
    A discrete site for general anesthetics on a postsynaptic receptor.
    S A Forman, K W Miller and G Yellen
    Molecular Pharmacology October 1995, 48 (4) 574-581;
  • You have access
    Involvement of a tyrosine kinase pathway in the growth-promoting effects of angiotensin II on aortic smooth muscle cells.
    I Leduc, P Haddad, E Giasson and S Meloche
    Molecular Pharmacology October 1995, 48 (4) 582-592;
  • You have access
    Phosphorylation of cyclic AMP response element-binding protein and induction of c-fos gene expression on withdrawal from chronic treatment with carbachol in NG108-15 cells.
    J M Thomas, J S Frazier, Z W Hu and B B Hoffman
    Molecular Pharmacology October 1995, 48 (4) 593-600;
  • You have access
    Angiotensin II down-regulates the vascular smooth muscle AT1 receptor by transcriptional and post-transcriptional mechanisms: evidence for homologous and heterologous regulation.
    B Lassègue, R W Alexander, G Nickenig, M Clark, T J Murphy and K K Griendling
    Molecular Pharmacology October 1995, 48 (4) 601-609;
  • You have access
    Differential effects of a topoisomerase I inhibitor on dioxin inducibility and high-level expression of the cytochrome P450IA1 gene.
    K Gradin, R Toftgård and A Berghard
    Molecular Pharmacology October 1995, 48 (4) 610-615;
  • You have access
    Activation and selective inhibition of a cyclic AMP-specific phosphodiesterase, PDE-4D3.
    R Alvarez, C Sette, D Yang, R M Eglen, R Wilhelm, E R Shelton and M Conti
    Molecular Pharmacology October 1995, 48 (4) 616-622;
  • You have access
    Presynaptic Ca2+/calmodulin-dependent protein kinase II: autophosphorylation and activity increase in the hippocampus after long-term blockade of serotonin reuptake.
    M Popoli, C Vocaturo, J Perez, E Smeraldi and G Racagni
    Molecular Pharmacology October 1995, 48 (4) 623-629;
  • You have access
    Developmental and endocrine regulation of P450 isoforms in rat breast.
    H Hellmold, J G Lamb, A Wyss, J A Gustafsson and M Warner
    Molecular Pharmacology October 1995, 48 (4) 630-638;
  • You have access
    Modulation of detoxification gene expression in human colon HT29 cells by glutathione-S-transferase inhibitors.
    P J Ciaccio, H Shen, A K Jaiswal, M H Lyttle and K D Tew
    Molecular Pharmacology October 1995, 48 (4) 639-647;
  • You have access
    Cloning and expression of a human metabotropic glutamate receptor 1 alpha: enhanced coupling on co-transfection with a glutamate transporter.
    M A Desai, J P Burnett, N G Mayne and D D Schoepp
    Molecular Pharmacology October 1995, 48 (4) 648-657;
  • You have access
    Eukaryotic DNA topoisomerases mediated DNA cleavage induced by a new inhibitor: NSC 665517.
    M Gupta, M Abdel-Megeed, Y Hoki, G Kohlhagen, K Paull and Y Pommier
    Molecular Pharmacology October 1995, 48 (4) 658-665;
  • You have access
    Pharmacological subtypes of the gamma-aminobutyric acidA receptors defined by a gamma-aminobutyric acid analogue 4,5,6,7-tetrahydroisoxazolo[5,4-c] pyridin-3-ol and allosteric coupling: characterization using subunit-specific antibodies.
    K H Huh, T M Delorey, S Endo and R W Olsen
    Molecular Pharmacology October 1995, 48 (4) 666-675;
  • You have access
    Yeast cysteine proteinase gene ycp1 induces resistance to bleomycin in mammalian cells.
    Z Pei, T P Calmels, C E Creutz and S M Sebti
    Molecular Pharmacology October 1995, 48 (4) 676-681;
  • You have access
    A structure-function relationship among reserpine and yohimbine analogues in their ability to increase expression of mdr1 and P-glycoprotein in a human colon carcinoma cell line.
    U G Bhat, M A Winter, H L Pearce and W T Beck
    Molecular Pharmacology October 1995, 48 (4) 682-689;
  • You have access
    Reversible modulation of opioid receptor binding in intact neural cells by endogenous guanosine triphosphate.
    N Yabaluri and F Medzihradsky
    Molecular Pharmacology October 1995, 48 (4) 690-695;
  • You have access
    Competition between positive and negative allosteric effectors on muscarinic receptors.
    J Proska and S Tucek
    Molecular Pharmacology October 1995, 48 (4) 696-702;
  • You have access
    Structural and ligand recognition properties of imidazoline binding proteins in tissues of rat and rabbit.
    B Lanier, R Raddatz, V Bakthavachalam, I Coupry, J L Neumeyer and S M Lanier
    Molecular Pharmacology October 1995, 48 (4) 703-710;
  • You have access
    Two classes of structurally different antagonists display similar species preference for the human tachykinin neurokinin3 receptor.
    F Z Chung, L H Wu, Y Tian, M A Vartanian, H Lee, J Bikker, C Humblet, M C Pritchard, J Raphy and N Suman-Chauhan
    Molecular Pharmacology October 1995, 48 (4) 711-716;
  • You have access
    Glycine modulates ethanol inhibition of heteromeric N-methyl-D-aspartate receptors expressed in Xenopus oocytes.
    A L Buller, H C Larson, R A Morrisett and D T Monaghan
    Molecular Pharmacology October 1995, 48 (4) 717-723;
  • You have access
    Structural requirements of analogues of polyamines for migration and growth of IEC-6 cells.
    S A McCormack, B J Zimmerman, M Israel, P Blanner and L R Johnson
    Molecular Pharmacology October 1995, 48 (4) 724-729;
  • You have access
    D2 dopamine receptor antisense oligodeoxynucleotide inhibits the synthesis of a functional pool of D2 dopamine receptors.
    Z H Qin, L W Zhou, S P Zhang, Y Wang and B Weiss
    Molecular Pharmacology October 1995, 48 (4) 730-737;
  • You have access
    Contribution of sequence and phosphorothioate content to inhibition of cell growth and adhesion caused by c-myc antisense oligomers.
    C Chavany, Y Connell and L Neckers
    Molecular Pharmacology October 1995, 48 (4) 738-746;
  • You have access
    Suppression of lipopolysaccharide-induced tumor necrosis factor-alpha generation from human peripheral blood monocytes by inhibitors of phosphodiesterase 4: interaction with stimulants of adenylyl cyclase.
    P M Seldon, P J Barnes, K Meja and M A Giembycz
    Molecular Pharmacology October 1995, 48 (4) 747-757;
  • You have access
    Dihydrofolate reductase binding and cellular uptake of nonpolyglutamatable antifolates: correlates of cytotoxicity toward methotrexate-sensitive and -resistant human head and neck squamous carcinoma cells.
    G Chen, J E Wright and A Rosowsky
    Molecular Pharmacology October 1995, 48 (4) 758-765;
  • You have access
    Lysophosphatidic acid regulation of cyclic AMP accumulation in cultured human airway smooth muscle cells.
    M Nogami, S M Whittle, D J Romberger, S I Rennard and M L Toews
    Molecular Pharmacology October 1995, 48 (4) 766-773;
  • You have access
    Comparative pharmacology of epibatidine: a potent agonist for neuronal nicotinic acetylcholine receptors.
    V Gerzanich, X Peng, F Wang, G Wells, R Anand, S Fletcher and J Lindstrom
    Molecular Pharmacology October 1995, 48 (4) 774-782;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 48, Issue 4
1 Oct 1995
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics